20 September 2022 : Original article
Long-Term Patency of All-in-One Sleeve Patch Graft Venoplasty in 16 Patients Who Underwent Living Donor Liver Transplantation with a Right Liver Graft: A 10-Year, Single-Center, Retrospective Study
Byeong-Gon NaDOI: 10.12659/AOT.936888
Ann Transplant 2022; 27:e936888
Table 1 Profiles of the 16 patients who underwent living donor liver transplantation using a right liver graft with outflow vein reconstruction through all-in-one sleeve venoplasty.
| Parameters | Values |
|---|---|
| Recipient age (years) | 53.6±6.7 |
| Recipient sex (n) | |
| Male | 12 (75.0%) |
| Female | 4 (25.0%) |
| Primary disease (n) | |
| HBV-associated liver cirrhosis | 8 (50.0%) |
| HCV-associated liver cirrhosis | 1 (6.3%) |
| Alcoholic liver disease | 3 (18.8%) |
| Cryptogenic liver cirrhosis | 1 (6.3%) |
| Budd-Chiari syndrome | 1 (6.3%) |
| Late graft failure | 2 (12.5%) |
| MELD score | 15.5±9.5 |
| Concurrent hepatocellular carcinoma (n) | 8 (50.0%) |
| ABO-incompatible transplantation (n) | 3 (18.8%) |
| Donor age (years) | 26.0±7.5 |
| Donor sex (n) | |
| Male | 12 (75.0%) |
| Female | 4 (25.0%) |
| Recipient-donor relation (n) | |
| Children | 14 (87.5%) |
| Son-in-law | 1 (6.3%) |
| Brother-in-law | 1 (6.3%) |
| Graft type (n) | |
| Modified right liver graft | 15 (93.8%) |
| Extended right liver graft | 1 (6.3%) |
| Graft-to-recipient weight ratio (%) | 1.11±0.29 |
| Ischemic time (minutes) | |
| Cold | 105.6±29.1 |
| Warm | 51.7±24.9 |
| Total | 157.4±40.9 |
| Post-transplant hospital stay (days) | |
| Recipient | 26.3±25.6 |
| Donor | 7.4±2.1 |
| Results are reported as mean±SD or as n (%). HBV – hepatitis B virus; HCV – hepatitis C virus; MELD – model for end-stage liver disease. | |






